pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

Steffen Ormanns(Ludwig-Maximilians-Universität München), Stefan Boeck(Ludwig-Maximilians-Universität München)

BMC Cancer

August 28, 2014

10.1186/1471-2407-14-624

Cited by 29

Related Papers

No related papers found

Powered by citation graph analysis